Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Microbiomics Acquires Metabolomics Firm MS-Omics

NEW YORK – Danish microbiome profiling firm Clinical Microbiomics said Monday that it has acquired metabolomics company MS-Omics for an undisclosed amount.

Copenhagen-based Clinical Microbiomics said the purchase would give it expertise in metabolite profiling and advance its systems biology platform, which is focused on exploring the microbiome and its connection to health and disease.

The acquisition follows a €10 million ($9.8 million) investment in Clinical Microbiomics from Seventure Partners that the company announced last week.

"There is an unmet need in the microbiome field for better solutions to integrate microbiome and metabolome data," Clinical Microbiomics CEO Anders Grøn said in a statement. "This demands a truly interdisciplinary approach — one that is made possible through this acquisition. We’re excited to engage with our network of researchers around the world to bring the new platform and services to work."

"This transaction is a big milestone for our companies," MS-Omics CEO Morten Danielsen said in a statement. "Together, we will be in position to offer a differentiated portfolio of services, lead the way with innovative concepts designed specifically for the fast-growing microbiome field, and benefit from improved sales coverage around the world."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.